{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T13:40:03Z","timestamp":1759066803073,"version":"3.44.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.bbr.2019.112220","type":"journal-article","created":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T11:12:29Z","timestamp":1568027549000},"page":"112220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Antidepressant effects of moxidectin, an antiparasitic drug, in a rat model of depression"],"prefix":"10.1016","volume":"376","author":[{"given":"Bruk","family":"Getachew","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yousef","family":"Tizabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2019.112220_bib0005","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4088\/JCP.14m09298","article-title":"The economic burden of adults with major depressive disorder in the United States, (2005 and 2010)","volume":"76","author":"Greenberg","year":"2015","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.bbr.2019.112220_bib0010","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00441-018-2978-8","article-title":"Monoaminergic system and depression","volume":"377","author":"Perez-Caballero","year":"2019","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.bbr.2019.112220_bib0015","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejphar.2019.02.024","article-title":"Molecular aspects of depression: a review from neurobiology to treatment","volume":"851","author":"Villas Boas","year":"2019","journal-title":"Eur. J. Pharmacol."},{"year":"2012","series-title":"World Federation for Mental Health","author":"World Federation for Mental Health","key":"10.1016\/j.bbr.2019.112220_bib0020"},{"year":"2015","series-title":"Awareness Month: by the Numbers","author":"National Institute of Mental Health","key":"10.1016\/j.bbr.2019.112220_bib0025"},{"key":"10.1016\/j.bbr.2019.112220_bib0030","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3389\/fpsyt.2015.00068","article-title":"Gene-environment interaction in major depression: focus on experience-dependent biological systems","volume":"6","author":"Lopizzo","year":"2015","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.bbr.2019.112220_bib0035","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3389\/fpsyt.2018.00334","article-title":"Genetics factors in major depression Disease","volume":"9","author":"Shadrina","year":"2018","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.bbr.2019.112220_bib0040","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.biopsych.2018.09.031","article-title":"The impact of stress and major depressive disorder on hippocampal and medial prefrontal cortex morphology","volume":"85","author":"Belleau","year":"2019","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.bbr.2019.112220_bib0045","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.472","article-title":"Depressive disorders: treatment failures and poor prognosis over the last 50 years","volume":"7","author":"Blackburn","year":"2019","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.bbr.2019.112220_bib0050","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3389\/fncel.2019.00087","article-title":"Cortical GABAergic dysfunction in stress and depression: new insights for therapeutic interventions","volume":"13","author":"Foga\u00e7a","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.bbr.2019.112220_bib0055","article-title":"Ketamine and NBQX both normalize alcohol-withdrawal induced depressive-like characteristics in rats","volume":"8","author":"Getachew","year":"2019","journal-title":"Jour. Drug Abuse Res."},{"key":"10.1016\/j.bbr.2019.112220_bib0060","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neuropharm.2015.10.034","article-title":"BDNF - a key transducer of antidepressant effects","volume":"102","author":"Bjorkholm","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2019.112220_bib0065","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1097\/00000542-200110000-00022","article-title":"Ketamine inhibits endotoxin-induced shock in rats","volume":"95","author":"Taniguchi","year":"2001","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bbr.2019.112220_bib0070","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/cns.12104","article-title":"Ketamine and peripheral inflammation","volume":"19","author":"De Kock","year":"2013","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.bbr.2019.112220_bib0075","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/7854_2016_40","article-title":"Inflammation effects on brain glutamate in depression: mechanistic considerations and treatment implications","volume":"31","author":"Haroon","year":"2017","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.bbr.2019.112220_bib0080","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1007\/s12035-018-1306-3","article-title":"Crosstalk between inflammation and glutamate system in depression: signaling pathway and molecular biomarkers for ketamine\u2019s antidepressant effect","volume":"56","author":"Cui","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbr.2019.112220_bib0085","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s12866-018-1373-7","article-title":"Ketamine interactions with gut-microbiota in rats: relevance to its antidepressant and anti-inflammatory properties","volume":"18","author":"Getachew","year":"2018","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.bbr.2019.112220_bib0090","article-title":"Moxidectin effects on gut microbiota of Wistar-Kyoto rats: relevance to depressive-like behavior","author":"Getachew","year":"2018","journal-title":"Clin. Pharm. Exp. Med."},{"key":"10.1016\/j.bbr.2019.112220_bib0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2019.111968","article-title":"Antidepressant effects of C-Terminal domain of the heavy chain of tetanus toxin in a rat model of depression","volume":"370","author":"Getachew","year":"2019","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2019.112220_bib0100","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.pbb.2011.08.014","article-title":"Alcohol induced depressive-like behavior is associated with a reduction in hippocampal BDNF","volume":"100","author":"Hauser","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbr.2019.112220_bib0105","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00213-013-3153-2","article-title":"Antidepressant effects of AMPA and ketamine combination: role of hippocampal BDNF, synapsin, and mTOR","volume":"230","author":"Akinfiresoye","year":"2013","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.bbr.2019.112220_bib0110","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neuroscience.2012.03.052","article-title":"Antidepressant-like effects of low ketamine dose is associated with increased hippocampal AMPA\/NMDA receptor density ratio in female Wistar-Kyoto rats","volume":"213","author":"Tizabi","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2019.112220_bib0115","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1253\/jcj.27.282","article-title":"Development of a strain of spontaneously hypertensive rats","volume":"27","author":"Okamoto","year":"1963","journal-title":"Jap. Circ. J."},{"key":"10.1016\/j.bbr.2019.112220_bib0120","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0031-9384(94)90097-3","article-title":"Open field, learned helplessness, conditioned defensive burying, and forced-swim tests in WKY rats","volume":"55","author":"Par\u00e9","year":"1994","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.bbr.2019.112220_bib0125","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0278-5846(02)00308-1","article-title":"Strain-dependent modification of behavior following antidepressant treatment","volume":"27","author":"Lopez-Rubalcava","year":"2003","journal-title":"Prog. Neuropsychopharm. Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2019.112220_bib0130","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/sj.mp.4001345","article-title":"Selectively bred Wistar-Kyoto rats: an animal model of depression and hyper-responsiveness to antidepressants","volume":"8","author":"Will","year":"2003","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbr.2019.112220_bib0135","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.pnpbp.2009.09.024","article-title":"Effects of nicotine on depressive-like behavior and hippocampal volume of female WKY rats","volume":"34","author":"Tizabi","year":"2010","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2019.112220_bib0140","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s12640-012-9348-1","article-title":"Neuroinflammation, neurodegeneration, and depression","volume":"23","author":"Hurley","year":"2013","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.bbr.2019.112220_bib0145","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1365-2885.1996.tb00062.x","article-title":"Avermectins and milbemycins","volume":"19","author":"McKellar","year":"1996","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.bbr.2019.112220_bib0150","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ijpddr.2012.04.001","article-title":"Moxidectin and the avermectins: consanguinity but not identity","volume":"14","author":"Prichard","year":"2012","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.bbr.2019.112220_bib0155","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/S1473-3099(18)30233-0","article-title":"Efficacy and tolerability of moxidectin alone and in co-administration with albendazole and tribendimidine versus albendazole plus oxantel pamoate against Trichuris trichiura infections: a randomised, non-inferiority, single-blind trial","volume":"18","author":"Barda","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.bbr.2019.112220_bib0160","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S1473-3099(18)30270-6","article-title":"Moxidectin for deworming: from trials to implementation","volume":"18","author":"Maheu-Giroux","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.bbr.2019.112220_bib0165","first-page":"229","article-title":"Effects of fenbendazole-impregnated feed and topical moxidectin during quarantine on the gut microbiota of C57BL\/6 mice","volume":"57","author":"Korte","year":"2018","journal-title":"J. Am. Assoc. Lab. Anim. Sci."},{"issue":"Pt A","key":"10.1016\/j.bbr.2019.112220_bib0170","first-page":"60","article-title":"Preclinical development of moxidectin as a novel therapeutic for alcohol use disorder","volume":"113","author":"Huynh","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2019.112220_bib0175","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1007\/s00213-018-4869-9","article-title":"Preclinical evaluation of avermectins as novel therapeutic agents for alcohol use disorders","volume":"235","author":"Khoja","year":"2018","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.bbr.2019.112220_bib0180","article-title":"Antidepressant for the treatment of people with co-ocurring depression and alcohol dependence","volume":"4","author":"Agabio","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.bbr.2019.112220_bib0185","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1007\/s12640-017-9859-x","article-title":"Low vs. high alcohol: central benefits vs. detriments","volume":"34","author":"Tizabi","year":"2018","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.bbr.2019.112220_bib0190","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.neulet.2018.01.022","article-title":"Sub-anesthetic doses of ketamine attenuate nicotine self-administration in rats","volume":"668","author":"Rezvani","year":"2018","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbr.2019.112220_bib0195","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.neulet.2017.12.055","article-title":"Both ketamine and NBQX attenuate alcohol drinking in male Wistar rats","volume":"666","author":"Ruda-Kucerova","year":"2018","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbr.2019.112220_bib0200","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1177\/1099800418776082","article-title":"Biological sex differences in depression: a systematic review","volume":"20","author":"Labaka","year":"2018","journal-title":"Biol. Res. Nurs."}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432819310599?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432819310599?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T13:15:26Z","timestamp":1759065326000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432819310599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":40,"alternative-id":["S0166432819310599"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2019.112220","relation":{},"ISSN":["0166-4328"],"issn-type":[{"type":"print","value":"0166-4328"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antidepressant effects of moxidectin, an antiparasitic drug, in a rat model of depression","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2019.112220","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112220"}}